31162826|t|Synthesis and Study of Multifunctional Cyclodextrin-Deferasirox Hybrids.
31162826|a|Metal dyshomeostasis is central to a number of disorders that result from, inter alia, oxidative stress, protein misfolding, and cholesterol dyshomeostasis. In this respect, metal deficiencies are usually readily corrected by treatment with supplements, whereas metal overload can be overcome by the use of metal-selective chelation therapy. Deferasirox, 4-[(3Z,5E)-3,5-bis(6-oxo-1-cyclohexa-2,4-dienylidene)-1,2,4-triazolidin-1-yl]benzoic acid, Exjade, or ICL670, is used clinically to treat hemosiderosis (iron overload), which often results from multiple blood transfusions. Cyclodextrins are cyclic glucose units that are extensively used in the pharmaceutical industry as formulating agents as well as for encapsulating hydrophobic molecules such as in the treatment of Niemann-Pick type C or for hypervitaminosis. We conjugated deferasirox, via an amide coupling reaction, to both 6A -amino-6A -deoxy-beta-cyclodextrin and 3A -amino-3A -deoxy-2A (S),3A (S)-beta-cyclodextrin, at the upper and lower rim, respectively, creating hybrid molecules with dual properties, capable of both metal chelation and cholesterol encapsulation. Our findings emphasize the importance of the conjugation of beta-cyclodextrin with deferasirox to significantly improve the biological properties and to decrease the cytotoxicity of this drug.
31162826	39	51	Cyclodextrin	Chemical	MESH:D003505
31162826	52	63	Deferasirox	Chemical	MESH:D000077588
31162826	73	78	Metal	Chemical	MESH:D008670
31162826	202	228	cholesterol dyshomeostasis	Disease	MESH:C535937
31162826	247	265	metal deficiencies	Disease	MESH:D013651
31162826	335	349	metal overload	Disease	MESH:D013651
31162826	380	385	metal	Chemical	MESH:D008670
31162826	415	426	Deferasirox	Chemical	MESH:D000077588
31162826	428	517	4-[(3Z,5E)-3,5-bis(6-oxo-1-cyclohexa-2,4-dienylidene)-1,2,4-triazolidin-1-yl]benzoic acid	Chemical	-
31162826	519	525	Exjade	Chemical	MESH:D000077588
31162826	530	536	ICL670	Chemical	MESH:D000077588
31162826	566	579	hemosiderosis	Disease	MESH:D006486
31162826	581	594	iron overload	Disease	MESH:D019190
31162826	651	664	Cyclodextrins	Chemical	MESH:D003505
31162826	676	683	glucose	Chemical	MESH:D005947
31162826	848	867	Niemann-Pick type C	Disease	MESH:D052556
31162826	875	891	hypervitaminosis	Disease	MESH:D006986
31162826	907	918	deferasirox	Chemical	MESH:D000077588
31162826	927	932	amide	Chemical	MESH:D000577
31162826	960	997	6A -amino-6A -deoxy-beta-cyclodextrin	Chemical	-
31162826	1002	1053	3A -amino-3A -deoxy-2A (S),3A (S)-beta-cyclodextrin	Chemical	-
31162826	1161	1166	metal	Chemical	MESH:D008670
31162826	1181	1192	cholesterol	Chemical	MESH:D002784
31162826	1268	1285	beta-cyclodextrin	Chemical	MESH:C031215
31162826	1291	1302	deferasirox	Chemical	MESH:D000077588
31162826	1374	1386	cytotoxicity	Disease	MESH:D064420
31162826	Association	MESH:D000077588	MESH:D003505
31162826	Association	MESH:D008670	MESH:C535937
31162826	Negative_Correlation	MESH:D000077588	MESH:D019190
31162826	Association	MESH:C031215	MESH:D064420
31162826	Negative_Correlation	MESH:D003505	MESH:D052556
31162826	Negative_Correlation	MESH:D000077588	MESH:D006486
31162826	Association	MESH:C031215	MESH:D000077588
31162826	Negative_Correlation	MESH:D003505	MESH:D006986

